For research and educational purposes only. Not medical advice.
Tesamorelin Reference
Educational, not medical advice reference for Tesamorelin: Fat Loss, GH Release; regulatory status, evidence posture, source review, and schedule notes. Also…
Reference summary
This entry displays only Egrifta WR label-reference fields. It does not approve or describe research-vial tesamorelin protocols.
- Categories
- Fat Loss, GH Release
- Aliases
- Egrifta WR, Growth hormone-releasing factor analog
- Evidence posture
- human
- Regulatory status
- FDA-approved label reference exists for Egrifta WR to reduce excess abdominal fat in HIV-infected adults with lipodystrophy; it is not indicated for weight-loss management.
- Content review status
- label verified